Track Mallinckrodt Plc - New's operating income ($-480M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Sep 30, 2026
Trailing 12 months ending Sep 30, 2026
As of the most recent data (September 2026), MNK shows a operating income of $-480M. That compares with $180M in the prior-year period — down 359.8% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, MNK's operating income is now $-480M (was $180M) — a 359.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Mallinckrodt Plc - New is outperforming or lagging.
Tracking MNK's operating income over time shows whether Mallinckrodt Plc - New is scaling, shrinking, or reshaping that part of the business. The current reading is $-480M That compares with $180M in the prior-year period — down 359.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this operating income page, Stockcircle has Mallinckrodt Plc - New's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-480M) with ownership activity and broader fundamentals.
Mallinckrodt Plc - New's operating income is $-480M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.